Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancerOxnard, G.R. ; Yang, J.C.-H. ; Yu, H. ; Kim, S.-W. ; Saka, H. ; Horn, L. ; Goto, K. ; Ohe, Y. ; Mann, H. ; Thress, K.S. ; Frigault, M.M. ; Vishwanathan, K. ; Ghiorghiu, D. ; Ramalingam, S.S. ; Ahn, M.-J.Annals of oncology, 2020-04, Vol.31 (4), p.507-516 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
136O Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trialAhn, M.-J. ; Yang, J. ; Yu, H. ; Saka, H. ; Ramalingam, S. ; Goto, K. ; Kim, S.-W. ; Yang, L. ; Walding, A. ; Oxnard, G.R.Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S115-S115 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic settingGoto, K. ; Satouchi, M. ; Ishii, G. ; Nishio, K. ; Hagiwara, K. ; Mitsudomi, T. ; Whiteley, J. ; Donald, E. ; McCormack, R. ; Todo, T.Annals of oncology, 2012-11, Vol.23 (11), p.2914-2919 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutationsIwama, E. ; Sakai, K. ; Azuma, K. ; Harada, T. ; Harada, D. ; Nosaki, K. ; Hotta, K. ; Ohyanagi, F. ; Kurata, T. ; Fukuhara, T. ; Akamatsu, H. ; Goto, K. ; Shimose, T. ; Kishimoto, J. ; Nakanishi, Y. ; Nishio, K. ; Okamoto, I.Annals of oncology, 2017-01, Vol.28 (1), p.136-141 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)Nokihara, H. ; Lu, S. ; Mok, T.S.K. ; Nakagawa, K. ; Yamamoto, N. ; Shi, Y.K. ; Zhang, L. ; Soo, R.A. ; Yang, J.C. ; Sugawara, S. ; Nishio, M. ; Takahashi, T. ; Goto, K. ; Chang, J. ; Maemondo, M. ; Ichinose, Y. ; Cheng, Y. ; Lim, W.T. ; Morita, S. ; Tamura, T.Annals of oncology, 2017-11, Vol.28 (11), p.2698-2706 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET studyShimokawa, M. ; Nosaki, K. ; Seto, T. ; Ohashi, K. ; Morise, M. ; Fujiwara, Y. ; Sakakibara, J. ; Murakami, H. ; Yano, S. ; Satouchi, M. ; Matsumoto, S. ; Goto, K. ; Yoh, K.Annals of oncology, 2019-04, Vol.30, p.ii66-ii66 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database ProjectShimizu, K. ; Nakaya, N. ; Saito-Nakaya, K. ; Akechi, T. ; Yamada, Y. ; Fujimori, M. ; Ogawa, A. ; Fujisawa, D. ; Goto, K. ; Iwasaki, M. ; Tsugane, S. ; Uchitomi, Y.Annals of oncology, 2012-08, Vol.23 (8), p.1973-1979 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trialKinoshita, I. ; Goda, T. ; Watanabe, K. ; Maemondo, M. ; Oizumi, S. ; Amano, T. ; Hatanaka, Y. ; Matsuno, Y. ; Nishihara, H. ; Asahina, H. ; Harada, T. ; Goto, K. ; Isobe, H. ; Nishimura, M. ; Dosaka-Akita, H.Annals of oncology, 2018-10, Vol.29, p.viii540-viii540 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancerNaito, T ; Seto, T ; Takeda, K ; Goto, K ; Okamoto, I ; Nakagawa, K ; Ohba, T ; Murakami, H ; Takahashi, T ; Yamanaka, T ; Yamamoto, NLung cancer (Amsterdam, Netherlands), 2014-12, Vol.86 (3), p.339-343 [Periódico revisado por pares]Oxford: Elsevier Ireland LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancerGOTO, K ; SEKINE, I ; TAMURA, T ; OHE, Y ; KUNITOH, H ; YAMAMOTO, N ; NOKIHARA, H ; YOSHIDA, K ; SUGIURA, T ; MATSUI, K ; SAIJO, N ; NISHIWAKI, Y ; KAKINUMA, R ; KUBOTA, K ; MATSUMOTO, T ; OHMATSU, H ; NIHO, S ; KODAMA, T ; SHINKAI, TBritish journal of cancer, 2004-08, Vol.91 (4), p.659-665 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |